冠状动脉粥样硬化性心脏病患者血浆微小RNA-34a水平对冠状动脉病变程度的影响

Effect of plasma microRNA-34a level on degree of coronary artery disease in coronary atherosclerotic heart disease patients

  • 摘要:
    目的 探讨冠状动脉粥样硬化性心脏病(CHD)患者血浆微小RNA-34a(miR-34a)水平与冠状动脉病变程度的相关性。
    方法 采集93例心血管内科住院患者的静脉血标本,采用紫外分光光度法检测血浆miR-34a水平。根据冠状动脉介入造影检查结果,将93例患者分为对照组(非CHD患者)20例与实验组(CHD患者)73例,并根据病变是否为冠状动脉慢性完全闭塞病变(CTO)将实验组患者分为CTO组18例与非CTO组55例。比较各组患者血浆miR-34a水平差异,采用受试者工作特征(ROC)曲线分析血浆miR-34a水平对冠状动脉病变的诊断价值,并分析CHD患者血浆miR-34a水平与SYNTAX评分、Gensini评分的相关性。
    结果 CTO组、非CTO组血浆miR-34a水平分别为(4.21±1.37)、(2.19±1.05), 均高于对照组的(1.10±0.27), 差异有统计学意义(P < 0.05); CTO组血浆miR-34a水平高于非CTO组,差异有统计学意义(P < 0.05)。CHD患者血浆miR-34a表达水平分别随着SYNTAX评分、Gensini评分的升高而呈现梯度上升趋势,各亚组间差异有统计学意义(P < 0.05)。ROC曲线显示,血浆miR-34a水平诊断冠状动脉病变(SYNTAX评分)的曲线下面积(AUC)为0.786, 95%CI为0.739~0.829, 敏感度为0.533, 特异度为0.892; 血浆miR-34a水平诊断冠状动脉病变(Gensini评分)的AUC为0.793, 95%CI为0.745~0.835, 敏感度为0.739, 特异度为0.746。相关性分析显示, CHD患者血浆miR-34a表达水平与SYNTAX评分、Gensini评分均呈显著正相关(r=0.084、0.076, P < 0.001)。
    结论 血浆miR-34a水平与CHD患者冠状动脉病变程度呈正相关,或可作为评估CHD患者冠状动脉病变程度的新型生物学指标。

     

    Abstract:
    Objective To explore the correlation between the level of plasma microRNA-34a(miR-34a) and the degree of coronary artery disease in patients with coronary atherosclerotic heart disease (CHD).
    Methods The venous blood samples of 93 hospitalized patients in cardiovascular department were collected, and the level of plasma miR-34a was detected by ultraviolet spectrophotometry. According to the results of coronary angiography, 93 patients were divided into control group (non-CHD patients, 20 cases) and experimental group (CHD patients, 73 cases). According to whether the lesions were chronic total occlusion of coronary artery (CTO) or not, the patients in the experimental group were divided into CTO group(18 cases) and non-CTO group(55 cases). The difference of plasma miR-34a level in each group was compared. The diagnostic value of plasma miR-34a level in coronary artery disease was analyzed by receiver operating characteristic (ROC) curve, and the correlations of plasma miR-34a level with SYNTAX score and Gensini score in patients with CHD were analyzed.
    Results Plasma miR-34A levels in the CTO group and non-CTO group were (4.21±1.37) and (2.19±1.05), respectively, which were higher than (1.10±0.27) in the control group (P < 0.05). The level of plasma miR-34a in the CTO group was higher than that in the non-CTO group (P < 0.05). The expression level of plasma miR-34a in CHD patients showed a gradient upward trend with the increase of SYNTAX score and Gensini score, and the differences among subgroups were statistically significant (P < 0.05). ROC curve showed that the area under curve (AUC) of plasma miR-34A level for diagnosing coronary artery lesions (SYNTAX score) was 0.786, with 95%CI of 0.739 to 0.829, sensitivity of 0.533, and specificity was 0.892. AUC of plasma miR-34a level for diagnosis of coronary artery disease (Gensini score) was 0.793, with 95% CI of 0.745 to 0.835, sensitivity of 0.739, and specificity of 0.746. Correlation analysis showed that plasma miR-34a expression level was significantly positively correlated with SYNTAX score and Gensini score in CHD patients (r=0.084, 0.076, P < 0.001).
    Conclusion The level of plasma miR-34a is positively correlated with the degree of coronary artery lesions in patients with CHD, which can be probably used as a new biological index to evaluate the degree of coronary artery lesions in these patients.

     

/

返回文章
返回